CD30 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD30 monoclonal antibodies for research focused on understanding CD30's role in various biological processes. CD30 monoclonal antibodies are compatible with multiple techniques including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD30, a member of the tumor necrosis factor receptor superfamily, plays a critical role in regulating immune responses and is primarily expressed on activated T and B lymphocytes. CD30's involvement in cell proliferation, differentiation, and apoptosis makes it a significant marker in the study of lymphoproliferative disorders and certain types of cancer, including Hodgkin's lymphoma. Understanding CD30 function is essential for developing targeted therapies and improving patient outcomes in related diseases. CD30 monoclonal antibodies enable detailed investigation of cellular pathways and molecular mechanisms. Researchers can explore CD30 expression patterns across different cell types and tissues to better understand its biological significance. CD30 monoclonal antibodies support cutting-edge research that advances scientific knowledge and potentially leads to breakthrough therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies for CD30 research contribute to advancing scientific understanding and therapeutic development in immunology and oncology.